New Search

If you are not happy with the results below please do another search

2034 search results for:

191

Bio-Rad and Element Biosciences Partner to Deliver Seamless RNA Sequencing Workflow Between Element’s AVITI™ System and Bio-Rad’s SEQuoia™ Express and SEQuoia™ Complete Stranded RNA Library Prep Kits

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, and Element Biosciences, Inc., developer of a new DNA sequencing platform disrupting genomics, today announced a partnership to demonstrate the capabilities of the Bio-Rad SEQuoia RNA Sequencing Library Preparation portfolio on the Element AVITI™ Benchtop Sequencer.

192

Bio-Rad Showcases Compatibility of SEQuoia™ RNA Library Preparation Kits with New Innovative Sequencers at AGBT 2023

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, has developed partnerships with leading innovative next-generation sequencing (NGS) instrument providers and announces compatibility of the SEQuoia RNA Sequencing Library Preparation portfolio on new state-of-the-art sequencers, including the Singular Genomics G4™ System.

193

New software enables remote 2D rack reading

DP5 is the latest version of Ziath’s market leading 2D rack decoding software. Drawing upon the latest  technologies, DP5 can be run from a laptop, desktop, phone, tablet, or any other network connected device. Using high-speed, web-based, communications protocols – DP5 allows users to run a single scanner in the lab, or multiple scanners connected […]

194

Bio-Rad’s CFX Opus Deepwell Dx Real-Time PCR System Advances Large Reaction Volume IVD Assay Development and Diagnostic Testing

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of the CFX Opus Deepwell Dx Real-Time PCR System, a real-time PCR system listed with the U.S. Food and Drug Administration (FDA) for in vitro diagnostic (IVD) testing, and developed in accordance with […]

197

Researchers show multi-cancer early detection potential of glycosaminoglycans as biomarkers

Swedish cancer detection company Elypta has published groundbreaking research showcasing the multi-cancer early detection (MCED) potential of glycosaminoglycans as biomarkers of tumour metabolism. The research conducted at Chalmers University of Technology by Elypta founders Prof. Jens Nielsen and Dr Francesco Gatto has been published in Proceedings of the National Academy of Sciences (PNAS). doi: https://doi.org/10.1073/pnas.2115328119

198

Fraunhofer Institute showcases mobile biological lab

Researchers from the Fraunhofer Institute for Biomedical Engineering (IBMT) have developed the “BioSensoLab“, a mobile biological laboratory with which they can demonstrate new developments to customers and test them together – on site at their companies. These new technologies rely in particular on intelligent sensors combined with artificial intelligence to perform analyses. The lab was […]

199

SmartChemistry platform to enable analysis on unprecedented scale

Asynt reports how the deepmatter Group, with facilities in the UK, France and Germany, have developed the cloud-based SmartChemistry platform to share chemical reaction and sensor data direct from the laboratory to allow analysis of this information on an unprecedented scale.